Article Details

General Atlantic-backed Centessa targets $1.7 billion valuation in US IPO

Retrieved on: 2021-05-24 13:30:00

Tags for this article:

Click the tags to see associated articles and topics

General Atlantic-backed Centessa targets $1.7 billion valuation in US IPO. View article details on hiswai:

Excerpt

(Reuters) – Centessa Pharmaceuticals Plc, the newly formed biopharma company backed by private equity firm General Atlantic, said on Monday it ...

Article found on: wtvbam.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up